IRIDEX (IRIX) vs PAVmed (PAVM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IRIDEX (IRIX) has outperformed PAVmed (PAVM) over the past year, losing 17.6% versus a loss of 81.1%. Over five years, IRIX leads with a -87.9% price change compared with -99.9% for PAVM. PAVmed is the larger company by market cap ($22.4 million vs $15.1 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRIX | PAVM |
|---|---|---|
| Share price | $0.859 | $2.80 |
| Market cap | $15.09M | $22.39M |
| 1-day change | -4.34% | +4.09% |
| YTD return | -21.23% | -59.43% |
| 1-year return | -17.61% | -81.12% |
| 5-year return | -87.88% | -99.90% |
| EPS (TTM) | $-0.20 | $-14.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $28.44 |
| 52-week low | $0.61 | $2.60 |
| Distance from 52-week high | -47.94% | -90.15% |
| Analyst consensus | none | none |
| Avg. price target upside | +220.14% | +1203.57% |
| Average volume | 389.24K | 30.34K |
| Shares outstanding | 17.56M | 8.00M |
| Employees | 93 | 41 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRIX has outperformed PAVM by 63.5 percentage points over the past year.
About IRIDEX
IRIX stock →IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 93 employees
About PAVmed
PAVM stock →PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
Health Care · Medical/Dental Instruments · 41 employees
IRIX vs PAVM FAQ
Which is bigger, IRIDEX or PAVmed?
PAVmed (PAVM) is larger, with a market capitalization of $22.39M compared with $15.09M for IRIDEX (IRIX).
Which stock has performed better over the past year, IRIX or PAVM?
IRIX returned -17.61% over the past 12 months, compared with -81.12% for PAVM (price return, excluding dividends). Past performance does not predict future results.
Are IRIDEX and PAVmed in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for IRIDEX and Medical/Dental Instruments for PAVmed.